https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Intranasal Drug and Vaccine Delivery Market (By Product: Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler, Others; By Application: Neurological Disorder, Pain Management, Respiratory Disorders, Vaccination, Others; By End Use: Retail Outlets, Hospital Pharmacies, Online Platform) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2021 - 2028

Published : Apr 2021

Report ID: ARC2175

Pages : 190

Format : Intranasal Drug and Vaccine Delivery Market (By Product: Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler, Others; By Application: Neurological Disorder, Pain Management, Respiratory Disorders, Vaccination, Others; By End Use: Retail Outlets, Hospital Pharmacies, Online Platform) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2021 - 2028

CHAPTER 1.Industry Overview of Intranasal Drug and Vaccine Delivery

1.1.Definition and Scope 

1.1.1.Definition of Intranasal Drug and Vaccine Delivery

1.1.2.Market Segmentation

1.1.3.Years Considered for the Study

1.1.4.Assumptions and Acronyms Used

1.1.4.1.Market Assumptions and Market Forecast

1.1.4.2.Acronyms Used in Global Intranasal Drug and Vaccine Delivery Market

1.2.Summary

1.2.1.Executive Summary 

1.2.2.Intranasal Drug and Vaccine Delivery Market By Product

1.2.3.Intranasal Drug and Vaccine Delivery Market By Application

1.2.4.Intranasal Drug and Vaccine Delivery Market By End Use

1.2.5.Intranasal Drug and Vaccine Delivery Market by Regions

CHAPTER 2.Research Approach

2.1.Methodology 

2.1.1.Research Programs

2.1.2.Market Size Estimation

2.1.3.Market Breakdown and Data Triangulation

2.2.Data Source

2.2.1.Secondary Sources

2.2.2.Primary Sources

CHAPTER 3.Market Dynamics And Competition Analysis

3.1.Market Drivers

3.1.1.Driver 1

3.1.2.Driver 2

3.2.Restraints and Challenges

3.2.1.Restrain 1

3.2.2.Restrain 2

3.3.Growth Opportunities

3.3.1.Opportunity 1

3.3.2.Opportunity 2 

3.4.Porter’s Five Forces Analysis

3.4.1.Bargaining Power of Suppliers

3.4.2.Bargaining Power of Buyers

3.4.3.Threat of Substitute

3.4.4.Threat of New Entrants

3.4.5.Degree of Competition

3.5.Market Concentration Ratio and Market Maturity Analysis of Intranasal Drug and Vaccine Delivery Market

3.5.1.Go To Market Strategy

3.5.1.1.Introduction

3.5.1.2.Growth

3.5.1.3.Maturity

3.5.1.4.Saturation

3.5.1.5.Possible Development

3.6.Technological Roadmap for Intranasal Drug and Vaccine Delivery Market

3.7.Value Chain Analysis

3.7.1.List of Key Manufacturers 

3.7.2.List of Customers

3.7.3.Level of Integration

3.8.Cost Structure Analysis

3.8.1.Price Trend of Key Raw Materials

3.8.2.Raw Material Suppliers

3.8.3.Proportion of Manufacturing Cost Structure

3.8.3.1.Raw Material

3.8.3.2.Labor Cost

3.8.3.3.Manufacturing Expense

3.9.Regulatory Compliance

3.10.Competitive Landscape, 2020

3.10.1.Player Positioning Analysis

3.10.2.Key Strategies Adopted By Leading Players

CHAPTER 4.Manufacturing Plant Analysis

4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020

4.2.R&D Status and Application Source of Intranasal Drug and Vaccine Delivery Major Manufacturers in 2020

CHAPTER 5.Intranasal Drug and Vaccine Delivery Market By Product

5.1.Introduction

5.2.Intranasal Drug and Vaccine Delivery Revenue By Product

5.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast, By Product, 2017-2028

5.2.2.Liquid Delivery Device

5.2.2.1.Liquid Delivery Device Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.3.Powder Delivery Device

5.2.3.1.Powder Delivery Device Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.4.Pressurized Metered Dose Inhaler

5.2.4.1.Pressurized Metered Dose Inhaler Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.5.Others

5.2.5.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 6.Intranasal Drug and Vaccine Delivery Market Revenue By Application

6.1.Introduction

6.2.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) By Application

6.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

6.2.2.Neurological Disorder

6.2.2.1.Neurological Disorder Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.3.Pain Management

6.2.3.1.Pain Management Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.4.Respiratory Disorders

6.2.4.1.Respiratory Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.5.Vaccination

6.2.5.1.Vaccination Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.6.Others

6.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 7.Intranasal Drug and Vaccine Delivery Market By End Use 

7.1.Introduction

7.2.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) By End Use

7.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

7.2.2.Retail Outlets

7.2.2.1.Retail Outlets Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.3.Hospital Pharmacies

7.2.3.1.Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.4.Online Platform

7.2.4.1.Online Platform Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 8.North America Intranasal Drug and Vaccine Delivery Market By Country 

8.1.North America Intranasal Drug and Vaccine Delivery Overview

8.2.U.S.

8.2.1.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

8.2.2.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

8.2.3.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.3.Canada

8.3.1.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

8.3.2.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

8.3.3.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.4.North America PEST Analysis

CHAPTER 9.Europe Intranasal Drug and Vaccine Delivery Market By Country

9.1.Europe Intranasal Drug and Vaccine Delivery Market Overview

9.2.U.K.

9.2.1.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

9.2.2.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.2.3.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

9.3.Germany

9.3.1.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

9.3.2.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.3.3.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

9.4.France

9.4.1.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

9.4.2.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.4.3.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

9.5.Spain

9.5.1.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

9.5.2.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.5.3.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

9.6.Rest of Europe

9.6.1.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028

9.6.2.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.6.3.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

9.7.Europe PEST Analysis

CHAPTER 10.Asia Pacific Intranasal Drug and Vaccine Delivery Market By Country

10.1.Asia Pacific Intranasal Drug and Vaccine Delivery Market Overview

10.2.China

10.2.1.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

10.2.2.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.2.3.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.3.Japan

10.3.1.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

10.3.2.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.3.3.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.4.India

10.4.1.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

10.4.2.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.4.3.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.5.Australia

10.5.1.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

10.5.2.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.5.3.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.6.South Korea

10.6.1.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

10.6.2.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.6.3.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.7.Rest of Asia-Pacific

10.7.1.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

10.7.2.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.7.3.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.8.Asia Pacific PEST Analysis

CHAPTER 11.Latin America Intranasal Drug and Vaccine Delivery Market By Country

11.1.Latin America Intranasal Drug and Vaccine Delivery Market Overview

11.2.Brazil

11.2.1.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

11.2.2.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

11.2.3.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

11.3.Mexico

11.3.1.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

11.3.2.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

11.3.3.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

11.4.Rest of Latin America

11.4.1.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

11.4.2.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028

11.4.3.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

CHAPTER 12.Middle East & Africa Intranasal Drug and Vaccine Delivery Market By Country 

12.1.Middle East & Africa Intranasal Drug and Vaccine Delivery Market Overview

12.2.Saudi Arabia

12.2.1.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

12.2.2.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

12.2.3.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

12.3.UAE

12.3.1.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

12.3.2.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

12.3.3.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

12.4.Rest of Middle East & Africa

12.4.1.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 - 2028

12.4.2.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

12.4.3.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

CHAPTER 13.Player Analysis Of Intranasal Drug and Vaccine Delivery

13.1.Intranasal Drug and Vaccine Delivery Market Company Share Analysis

13.2.Competition Matrix

13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2.New Product Launches and Product Enhancements

13.2.3.Mergers And Acquisition In Global Intranasal Drug and Vaccine Delivery Market

13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14.COMPANY PROFILE

14.1.Aegis Therapeutics LLC

14.1.1.Company Snapshot

14.1.2.Business Overview

14.1.3.Financial Overview

14.1.3.1.Revenue (US$ Mn), 2020

14.1.3.2.Aegis Therapeutics LLC 2020 Intranasal Drug and Vaccine Delivery Business Regional Distribution

14.1.4.Product/ Service and Specification

14.1.5.Recent Developments & Business Strategy

14.1.6.Manufacturing Plant Footprint Analysis

14.2.AstraZeneca Plc

14.3.MedImmune, Inc.

14.4.Alza Corporation

14.5.Baxter International, Inc.

14.6.Becton, Dickinson and Company 

14.7.GlaxoSmithKline Plc.

14.8.Johnson & Johnson, Inc.

14.9.Others

Frequently Asked Questions

What will be the market value of Intranasal Drug and Vaccine Delivery in 2028?

The Intranasal Drug and Vaccine Delivery market value is anticipated to be worth around US$ 60 Bn in 2028.

What will be the CAGR of Intranasal Drug and Vaccine Delivery market?

The Intranasal Drug and Vaccine Delivery market is anticipated to grow around 7.1% CAGR amid the forecast period 2021-2028.

Which region held highest share in 2019 in the global Intranasal Drug and Vaccine Delivery market?

North America held highest market share in 2019.

Which region is projected to be the fastest growing region in the global Intranasal Drug and Vaccine Delivery market?

Asia Pacific is projected to be the fastest growing region in the global market.

Which are the key players of Intranasal Drug and Vaccine Delivery market?

The key players operating in Intranasal Drug and Vaccine Delivery market such as Aegis Therapeutics LLC, AstraZeneca Plc, MedImmune, Inc., Alza Corporation, Baxter International, Inc., Becton, Dickinson and Company, GlaxoSmithKline Plc., Johnson & Johnson, Inc., and Others.

Which insight provides on the Intranasal Drug and Vaccine Delivery market?

The report provides insights on global Intranasal Drug and Vaccine Delivery market segment by product, application, end use and major geographic regions.

What is the geographically segments of Intranasal Drug and Vaccine Delivery market?

The Intranasal Drug and Vaccine Delivery market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date